Insulin and wound healing

Burns

Volumn 40, Issue 8, 2014, Pages 1433-1446

  Hrynyk, Michael ^a   Neufeld, Ronald J ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Biologicals; Burns; Insulin; Peptide delivery; Wound healing

Indexed keywords

GLUCOSE; INSULIN; INSULIN RECEPTOR; ANTIDIABETIC AGENT;

BURN; CELL DIVISION; CELL MIGRATION; CELLS BY BODY ANATOMY; CRYSTALLIZATION; DEATH; DRUG DELIVERY SYSTEM; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INSULIN SYNTHESIS; INSULIN TREATMENT; MORBIDITY; NONHUMAN; REVIEW; SYSTEMIC CIRCULATION; TISSUE REPAIR; WOUND; WOUND DRESSING; WOUND HEALING; WOUND HEALING IMPAIRMENT; ANIMAL; BURNS; CELL MOTION; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT;

ANIMALS; BURNS; CELL MOVEMENT; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; PROTEIN TRANSPORT; RECEPTOR, INSULIN; WOUND HEALING;

EID: 84922015980     PISSN: 03054179     EISSN: 18791409     Source Type: Journal    
DOI: 10.1016/j.burns.2014.03.020     Document Type: Review

References (131)

1. Velnar T, Bailey T, Smrkoli V. The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res 2009;37:1528-42.
2. Wardrope J, Edhouse JA. The management of wounds and burns. New York: Oxford University Press; 1999.
3. Barret-Nerin JP, Herndon DN. Principles and practice of burn surgery. New York: Marcel Dekker; 2005.
4. Queen D, Evans JH, Gaylor JDS, Courtney JM, Reid WH. Burn wound dressings - a review. Burns 1987;13:218-28.
5. Winter GD. Formation of the scab and the rate of epithelization of superficial wounds in the skin of the young domestic pig. Nature 1962;193:293-4.
6. Quinn KJ, Courtney JM, Evans JH, Gaylor JDS, Reid WH. Principles of burn dressings. Biomaterials 1985;6:369-77.
7. Holcomb JB, Pusateri AE, Hess JR, Hetz SP, Harris RA, Tock BB, et al. Implications of new dry fibrin sealant technology for trauma surgery. Surg Clin North Am 1997;77:943-52.
8. Hom DB, Adams G, Koreis M, Maisel R. Choosing the optimal wound dressing for irradiated soft tissue wounds. Otolaryngol Head Neck Surg 1999;121:591-8.
9. Van der Veen VC, Van der Wal MBA, Van Leeuwen MCE, Ulrich MMW, Middelkoop E. Biological background of dermal substitutes. Burns 2010;36:305-21.
10. Windmaier E, Raff H, Strang KT, editors. Human physiology: the mechanisms of body function. 9th ed. New York: McGraw-Hill; 2004.
11. Hardwicke J, Schmaljohann D, Boyce D, Thomas D. Epidermal growth factor therapy and wound healing - past, present and future perspectives. Surgeon 2008;6:172-7.
12. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen 2008;16:585-601.
13. Walsh G. Biopharmaceuticals: recent approvals and likely directions. Trends Biotechnol 2005;23:553-8.
14. Aberra FN, Lichtenstein GR. Infliximab in ulcerative colitis. Gastroenterol Clin North Am 2006;35:821-36.
15. Golzio M, Mazzolini L, Moller P, Rols MP, Teissié J. Inhibition of gene expression in mice muscle by in vivo electrically mediated siRNA delivery. Gene Ther 2005;12:246-51.
16. Ferrer-Miralles N, Domingo-Espin J, Corchero J, Vazquez E, Villaverde A. Microbial factories for recombinant pharmaceuticals. Microb Cell Fact 2009;8:17.
17. Liu Y, Petreaca M, Yao M, Martins-Green M. Cell and molecular mechanisms of keratinocyte function stimulated by insulin during wound healing. BMC Cell Biol 2009;10:1-15.
18. Stevenson CL. Advances in peptide pharmaceuticals. Curr Pharm Biotechnol 2009;10:122-37.
19. Thomas DA, O'Brien S, Kantarjian HM. Monoclonal antibody therapy with rituximab for acute lymphoblastic leukemia. Hematol Oncol Clin North Am 2009;23:949-71.
20. Parker MH, Birck-Wilson E, Allard G, Masiello N, Day M, Murphy KP, et al. Purification and characterization of a recombinant version of human a-fetoprotein expressed in the milk of transgenic goats. Protein Expr Purif 2004;38:177-83.
21. Dudley-Brown S, Nag A, Cullinan C, Ayers M, Hass S, Panjabi S. Health-related quality-of-life evaluation of Crohn disease patients after receiving natalizumab therapy. Gastroenterol Nurs 2009;32:327-39.
22. Nimni ME. Polypeptide growth factors: targeted delivery systems. Biomaterials 1997;18:1201-25.
23. Tabata Y, Yamamoto M, Ikada Y. Biodegradable hydrogels for bone regeneration through growth factor release. Pure Appl Chem 1998;70:1277-82.
24. Orgill D, Demling RH. Current concepts and approaches to wound healing. Crit Care Med 1988;16:899-908.
25. Tanaka A, Nagate T, Matsuda H. Acceleration of wound healing by gelatin film dressings with epidermal growth factor. J Vet Med Sci 2005;67:909-13.
26. Puolakkainen PA, Twardzik DR, Ranchalis JE, Pankey SC, Reed MJ, Gombotz WR. The enhancement in wound healing by transforming growth factor-β1 (TGF-β1) depends on the topical delivery system. J Surg Res 1995;58:321-9.
27. Judith R, Nithya M, Rose C, Mandal AB. Application of a PDGF-containing novel gel for cutaneous wound healing. Life Sci 2010;87:1-8.
28. Schein CH. Production of soluble recombinant proteins in bacteria. Nature 1989;7:1141-9.
29. Robertson JS. Changes in biological source material. Biologicals 2006;34:61-3.
30. Allan FN. Diabetes before and after insulin. Med Hist 1972;16:266-73.
31. Allen FM, Du Bois EF. Clinical calorimetry. Arch Intern Med 1916;17:1010-59.
32. De Meyts P. Insulin and its receptor: structure, function and evolution. Bioessays 2004;26:1351-62.
33. Bliss M. The discovery of insulin. Toronto: McClelland and Stewart Ltd.; 1982.
34. Abel JJ. Crystalline insulin. Proc Natl Acad Sci U S A 1926;12:132-6.
35. Sanger F, Thompson EOP, Kitai R. The amide groups of insulin. Biochem J 1955;59:509-18.
36. Steiner DF, Cunningham D, Spigelman L, Aten B. Insulin biosynthesis: evidence for a precursor. Science 1967;157:697-700.
37. Adams MJ, Blundell TL, Dodson EJ, Dodson GG, Vijayan M, Baker EN, et al. Structure of rhombohedral 2 zinc insulin crystals. Nature 1969;224:491-5.
38. Ullrich A, Gray A, Tam A, Yangfeng T, Tsubokawa M, Collins C, et al. Insulin-like growth factor-i receptor primary structure - comparison with insulin-receptor suggests structural determinants that define functional specificity. EMBO J 1986;5:2503-12.
39. Watkins P. Choice of insulin. Br Med J 1983;287:1571-2.
40. Ashcroft FM, Ashcroft SJH, editors. Insulin molecular biology to pathology. New York: Oxford University Press; 1992.
41. Catt K. ABC of endocrinology VIII - insulin and glucose homoeostasis. Lancet 1970;2:353-8.
42. Nielsen D, Welsh M, Casadaban M, Steiner D. Control of insulin gene-expression in pancreatic beta-cells and in an insulin-producing cell-line, Rin-5f cells 1. Effects of glucose and cyclic-amp on the transcription of insulin messenger-Rna Rid B-4655-2009. J Biol Chem 1985;260:3585-9.
43. Halban PA. Proinsulin trafckin and processing in the pancreatic B cell. Trends Endocrinol Metabol 1990;1:261-5.
44. Cooper GM, editor. The cell: a molecular approach. Sunderland, MA: Sinauer Associates; 2000.
45. Emdin S, Dodson G, Cutfield J, Cutfield S. Role of zinc in insulin biosynthesis. Diabetologia 1980;19:174-82.
46. Duckworth WC, Bennett RG, Hamel FG. Insulin degradation: progress and potential. Endocr Rev 1998;19:608-24.
47. Duckworth WC, Fawcett J, Reddy S, Page JC. Insulin-degrading activity in wound fluid. J Clin Endocrinol Metab 2004;89:847-51.
48. Vimalavathini R, Gitanjali B. Effect of temperature on the potency and pharmacological action of insulin. Indian J Med Res 2009;130:166-9.
49. Strickley RG, Anderson BD. Solid-state stability of human insulin I. Mechanism and the effect of water on the kinetics of degradation in lyophiles from pH 2-5 solutions. Pharm Res 1996;13:1142-53.
50. Ladisch MR, Kohlmann KL. Recombinant human insulin. Biotechnol Prog 1992;8:469-78.
51. Petrides D, Sapidou E, Calandranis J. Computer-aided process analysis and economic evaluation for biosynthetic human insulin production - a case study. Biotechnol Bioeng 1995;48:529-41.
52. Smith G, Swenson D, Dodson E, Dodson G, Reynolds C. Structural stability in the 4-zinc human insulin hexamer. Proc Natl Acad Sci U S A 1984;81:7093-7.
53. Scott D, Fisher A. Crystalline insulin. Biochem J 1935;29:1048-54.
54. Wagner A, Diez J, Schulze-Briese C, Schluckebier G. Crystal structure of ultralente - a microcrystalline insulin suspension. Proteins 2009;74:1018-27.
55. Lee J, Pilch PF. The insulin receptor: structure, function, and signaling. Am J Physiol Cell Physiol 1994;266:C319-34.
56. Watanabe M, Hayasaki H, Tamayama T, Shimada M. Histological distribution of insulin and glucagon receptors. Braz J Med Biol Res 1998;31:243-56.
57. Soderman DD, Germershausen J, Katzen HM. Affinity binding of intact fat cells and their ghosts to immobilized insulin. PNAS 1973;70:792-6.
58. Soda R, Tavassoli M. Distribution of insulin receptors in liver cell suspensions using a minibead probe. Exp Cell Res 1983;145:389-95.
59. Dons RF, Corash LM, Gorden P. The insulin receptor is an age-dependent integral component of the human erythrocyte membrane. J Biol Chem 1981;256:2982-7.
60. Gavin JR, Roth J, Jen P, Freychet P. Insulin receptors in human circulating cells and fibroblasts. Proc Natl Acad Sci U S A 1972;69:747-51.
61. Hollenberg MD, Cuatrecasas P. Insulin and epidermal growth factor. J Biol Chem 1975;250:3845-53.
62. Verrando P, Ortonne JP. Insulin receptors in cultured human keratinocytes. Br J Dermatol 1984;111:232-4.
63. Elsas LJ, Endo F, Strumlauf E, Elders J, Priest JH. Leprechaunism: an inherited defect in a high-affinity insulin receptor. Am J Hum Genet 1985;37:73-88.
64. Wertheimer E, Trebicz M, Eldar T, Gartsbein M, Nofeh-Moses S, Tennenbaum T. Differential roles of insulin receptor and insulin-like growth factor-1 receptor in differentiation of murine skin keratinocytes. J Invest Dermatol 2000;115:24-9.
65. Saltiel AR, Pessin JE, editors. Mechanism of insulin action. New York: Springer; 2007.
66. Bravo DA, Gleason JB, Sanchez BI, Roth RA, Fuller RS. Accurate and efficient cleavage of the human insulin proreceptor by the human proprotein-processing protease furin. J Biol Chem 1994;269:25830-7.
67. Seino S, Bell GI. Alternative splicing of human insulin receptor messenger RNA. Biochem Biophys Res Commun 1989;159:312-6.
68. Ullrich A, Bell JR, Chen EY, Herrera R, Petruzelli M, Dull TJ, et al. Human insulin receptor and its relationship to the tyronsine kinase family of oncogenes. Nature 1985;313:756-61.
69. Wang S, Wang L, Shan Y, Wang Y, Li W, Sun C. Binding mode of insulin receptor and agonist peptide. Chem Res Chin Univ 2006;22:242-4.
70. Fantl WJ, Johnson DE, Williams LT. Signalling by receptor tyrosine kinases. Annu Rev Biochem 1993;62:453-81.
71. Lawrence MC, McKern NM, Ward CW. Insulin receptor structure and its implications for the IGF-1 receptor. Curr Opin Struct Biol 2007;17:699-705.
72. Menting JG, Ward CW, Margetts MB, Lawrence MC. A thermodynamic study of ligand binding to the first three domains of the human insulin receptor: relationship between the receptor a-chain C-terminal peptide and the site 1 insulin mimetic peptides. Biochemistry 2009;48:5492-500.
73. Becker AB, Rother RA. Insulin receptor structure and function in normal and pathological conditions. Annu Rev Med 1990;41:99-115.
74. Patti ME, Kahn CR. The insulin receptor - a critical link in glucose homeostasis and insulin action. J Basic Clin Physiol Pharmacol 1998;9:89-109.
75. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001;414:799-806.
76. Pessin JE, Saltiel AR. Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 2000;106:165-9.
77. Kuhné MR, Pawson T, Lienhard GE, Feng GS. The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp. J Biol Chem 1993;268:11479-81.
78. Lima MHM, Caricilli AM, De Abreau LL, Araujo EP, Pelegrinelli FF, Thirone ACP, et al. Topical insulin accelerates wound healing in diabetes by enhancing the AKT and ERK pathways: a double-blind placebo-controlled clinical trial. PLOS ONE 2012;7:e36974.
79. Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, et al. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 1991;352:73-7.
80. Di Guglielmo GM, Baass PC, Authier F, Posner BI, Bergeron JM. Insulin receptor internalization and signaling. Mol Cell Biochem 1998;182:59-63.
81. Goldstein BJ, Bittner-Kowalczyk A, White MF, Harbeck M. Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. J Biol Chem 2000;275:4283-9.
82. Gurd FB. Postoperative use of insulin in the nondiabetic. Ann Surg 1937;106:761-9.
83. Thalhimer W. Insulin treatment of postoperative (nondiabetic) acidosis. J Am Med Assoc 1923;81:383-5.
84. Foster NB. Diabetic coma. J Am Med Assoc 1925;84:719-22.
85. Schazzillo BA, Ksendowsky MJ. Der wirkung des insulins auf die regeneration. Die biologische rolle der K-und Caionen bei diesem vorgange. Pfliig Arch ges Physiol 1928;220:774-8.
86. Joseph B. Insulin in the treatment of non-diabetic bed sores. Ann Surg 1930;92:318-9.
87. Rabinowitch IM. On the mortality resulting from surgical treatment of chronic gall-bladder disease in diabetes mellitus. Ann Surg 1932;96:70-4.
88. Stuck W. The effect of insulin on healing of experimental fractures in the rabbit. J Bone Joint Surg 1932;14:109-15.
89. Lawrence RT, Salter JM, Best CH. The effect of insulin on nitrogen retention in the hypophysectomized rat. Br Med J 1954;2:437-9.
90. Stunkle G, Wray JB. The effect of exogenous insulin on fracture healing in the intact rat. Clin Orthop Relat Res 1965;40:30-4.
91. Bolli GB, Di Marchi RD, Park GD, Pramming S, Koivisto VA. Insulin analogues and their potential in the management of diabetes mellitus. Diabetologia 1999;42:1151-67.
92. Gregory WB. Effect of insulin on the healing of bone wounds in albino rats. J Dent Res 1965;44:487-92.
93. Paul TN. Treatment by local application of insulin of an infected wound in a diabetic. Lancet 1966;2:574-6.
94. Rosenthal SP. Acceleration of primary wound healing by insulin. Arch Surg 1968;96:53-5.
95. Belfield WO, Golinsky S, Compton MD. The use of insulin in open-wound healing. Vet Med Small Anim Clin 1970;65:455-60.
96. Udupa KN, Chansouria JPN. The role of protamine zinc insulin in accelerating wound healing in the rat. Br J Surg 1971;58:673-5.
97. Goodson WH, Hunt TK. Wound-healing In experimental diabetes-mellitus - importance of early insulin therapy. Surg Forum 1978;29:95-8.
98. Weringer EJ, Kelso JM, Tamai IY, Arquilla ER. Effects of insulin on wound healing in diabetic mice. Acta Endocrinol (Copenh) 1982;101-8.
99. Sakurai Y, Aarsland A, Herndon DN, Chinkes DL, Pierre EJ, Nguyen TT, et al. Stimulation of muscle protein synthesis by long-term insulin infusion in severely burned patients. Ann Surg 1995;222:283-97.
100. Pierre EJ, Barrow RE, Hawkins HK, Nguyen TT, Sakurai Y, Desai M, et al. Effects of insulin on wound healing. J Trauma 1998;44:342-5.
101. Zhang XJ, Chinkes DL, Wolf SE, Wolfe RR. Insulin but not growth hormone stimulates protein anabolism in skin wound and muscle. Am J Physiol Endocrinol Metab 1999;276:E712-20.
102. Zhang XJ, Chinkes DL, Irtun O, Wolfe RR. Anabolic action of insulin on skin wound protein is augmented by exogenous amino acids. Am J Physiol Endocrinol Metab 2002;282:E1308-15.
103. Gore I, Wolf SE, Herndon DN, Wolfe RR. Relative influence of glucose and insulin on peripheral amino acid metabolism in severely burned patients. J Parenter Enteral Nutr 2002;26:271-7.
104. Cree MG, Zwetsloot JJ, Herndon DN, Newcomer BR, Fram RY, Angel C, et al. Insulin sensitivity is related to fat oxidation and protein kinase C activity in children with acute burn injury. J Burn Care Res 2008;29:585-94.
105. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-67.
106. Jeschke MG, Boehning DF, Finnerty CC, Herndon DN. Effect of insulin on the inflammatory and acute phase response after burn injury. Crit Care Med 2007;35:S519-23.
107. Jeschke MG, Kulp GA, Kraft R, Finnerty CC, Mlcak R, Lee JO, et al. Intensive insulin therapy in severely burned pediatric patients. Am J Respir Crit Care Med 2010;182:351-9.
108. Jeschke MG, Finnerty CC, Herndon DN, Song J, Boehning D, Tompkins RG, et al. Severe injury is associated with insulin resistance, endoplasmic reticulum stress response, and unfolded protein response. Ann Surg 2012;255:370-8.
109. Kabalak AA, Ceylan A, Vural C. Effect of insulin treatment to systemic inflammatory response in burn injury. N Engl J Med 2013;30:191-4.
110. Rezvani O, Shabbak E, Aslani A, Bidar R, Jafari M, Safarnezhad S. A randomized, double-blind, placebo-controlled trial to determine the effects of topical insulin on wound healing. Ostomy Wound Manage 2009;55:22-8.
111. Wilson JM, Baines R, Babu ED, Kelley CJ. A role for topical insulin in the management of problematic surgical wounds. Ann R Coll Surg Engl 2008;90:160-6.
112. Fram RY, Cree MG, Wolfe RR, Mlcak RP, Qian T, Chinkes DL, et al. Intensive insulin therapy improves insulin sensitivity and mitochondrial function in severely burned children. Crit Care Med 2010;38:1475-83.
113. Scimeca CL, Bharara M, Fisher TK, Kimbriel H, Mills JL, Armstrong DG. Novel use of insulin in continuous-instillation negative pressure wound therapy as wound chemotherapy. J Diab Sci Technol 2010;4:820-4.
114. Tuvdendorj D, Zhang X, Chinkes DL, Aarsland A, Kulp GA, Jeschke MG, et al. Intensive insulin treatment increases donor site wound protein synthesis in burn patients. Surgery 2011;149:512-8.
115. Zhang X, Chinkes DL, Sadagopa Ramanujam VM, Wolfe RR. Local injection of insulin-zinc stimulates DNA synthesis in skin donor site wound. Wound Repair Regen 2007;15:258-65.
116. Zhang X, Wu X, Wolf SE, Hawkins HK, Chinkes DL, Wolfe RR. Local insulin-zinc injection accelerates skin donor site wound healing. J Surg Res 2007;142:90-6.
117. Zhang X, Meng C, Chinkes DL, Herndon DN. Beneficial effects of insulin on cell proliferation and protein metabolism in skin donor site wound. J Surg Res 2011;168:e155-61.
118. Zagon IS, Sassani JW, McLaughlin PJ. Insulin treatment ameliorates impaired corneal reepithelialization in diabetic rats. Diabetes 2006;55:1141-7.
119. Zagon IS, Klocek MS, Sassani JW, McLaughlin PJ. Use of topical insulin to normalize corneal epithelial healing in diabetes mellitus. Arch Ophthalmol 2007;125:1082-8.
120. Zhang WF, Zhu XX, Hu DH, Xu CG, Wang YC, Lv GF. Intensive insulin treatment attenuates burn-initiated acute lung injury in rats: role of the protective endothelium. J Burn Care Res 2011;32:e51-8.
121. Wang Z, Liu L, Hu T, Lei W, Wan F, Zhang P, et al. Protective effect of glucose-insulin-potassium (GIK) on intestinal tissues after severe burn in experimental rats. Burns 2012;38:846-54.
122. Jeschke MG, Kraft R, Song J, Gauglitz GG, Cox RA, Brooks NC, et al. Insulin protects against hepatic damage postburn. Mol Med 2011;17:516-22.
123. Chen J, Zhang X, Liu Y. Effect of topical insulin application on wound neutrophil function. Wounds 2012;24:178-84.
124. Zhang Q, Ma BY, Cyr E, Mcintosh LJ, Fishman AJ, Tompkins RG, et al. Role of brown adipose tissue (BAT) in burn-induced insulin resistance. J Invest Biochem 2013;2:85-92.
125. Yano H, Keiichi O, Amagasa T. Insulin enhancement of in vitro healing in fetal rat parietal bone. J Oral Maxillofac Surg 1996;54:182-6.
126. Huang JS, Mukherjee JJ, Chung T, Crilly KS, Kiss Z. Extracellular calcium stimulates DNA synthesis in synergism with zinc, insulin and insulin-like growth factor I in fibroblasts. Eur J Biochem 1999;266:943-51.
127. Shanley LJ, McCaig CD, Forrester JV, Zhao M. Insulin, not leptin, promotes in vitro cell migration to heal monolayer wounds in human corneal epithelium. Invest Ophthalmol Vis Sci 2004;45:1088-94.
128. Musselmann K, Alexandrou B, Kane B, Hassell JR. Maintenance of the keratocyte phenotype during cell proliferation stimulation by insulin. J Biol Chem 2005;280:32634-9.
129. Liu Y, Petreaca M, Martins-Green M. Cell and molecular mechanisms of insulin-induced angiogenesis. J Cell Mol Med 2008;13:4492-504.
130. Hrynyk M, Martins-Green M, Barron AE, Neufeld RJ. Alginate-PEG sponge architecture and role in the design of insulin release dressings. Biomacromolecules 2012;13:1478-85.
131. Hrynyk M, Martins-Green M, Barron AE, Neufeld RJ. Sustained prolonged topical delivery of bioactive human insulin for potential treatment of cutaneous wounds. Int J Pharm 2010;398:146-54.